This article corrects:

  1. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia Volume 26, Issue 3, 549–553, Article first published online: 15 February 2011

In the February 15, 2011 issue of Movement Disorders, in the Brief Report entitled “The c.-237_236GA>TT THAP1 Sequence Variant Does Not Increase Risk for Primary Dystonia” (Volume 26, Issue 3, Pages 549–553, DOI 10.1002/mds.23551), by Xiao et al., the grant information and acknowledgments were missing. The missing information is given below:

Funding agencies: This study was supported by the Neuroscience Institute at the University of Tennessee Health Science Center (to M.S.L.), Dystonia Medical Research Foundation (to M.S.L.), NIH grants R01NS048458 and R01NS069936 (to M.S.L.), NIH U54 Dystonia Coalition (1U54NS065701) Pilot Projects Program (to M.S.L.), and the Parkinson's & Movement Disorder Foundation (to M.S.L.). At Washington University School of Medicine, work was supported by the NIH National Institute of Neurological Disease and Stroke grants P30NS05710 (Neuroscience Blueprint Grant) and Clinical Sciences Translation Award RR024992, K24 ES017765 (to B.A.R.), the American Parkinson's Disease Association (APDA) Advanced Research Center, the Greater St. Louis Chapter of the APDA, the Barnes-Jewish Hospital Foundation (Jack Buck Fund for PD Research and the Elliot H. Stein Family Fund), the Missouri Chapter of the Dystonia Medical Research Foundation and the Murphy Fund. At Mayo Clinic Florida, work was supported by the NIH National Institute of Neurological Disease and Stroke Morris K. Udall Center of Excellence for Parkinson Disease Research grant (P50-NS40256), NIA R01AG015866 and Bolch Family Foundation (to Z.K.W., R.J.U., and J.A.V.G.); NINDS R01 NS057567-01A2, Pacific Alzheimer's Research Foundation (PARF-C06-01), and CR 90052025 Mayo Clinic Jacksonville Research Committee (to Z.K.W. and R.J.U.); and NIA P01AG017216 (to Z.K.W.). At the Parkinson's & Movement Disorder Institute, work was supported by the Long Beach Memorial Foundation, Orange Coast Memorial Foundation, and the Parkinson's & Movement Disorder Foundation. Collection of control specimens at Emory University was supported by the Alzheimer's Disease Research Center Grant AG025688 and Emory NINDS Neuroscience Core Facilities Grant NS055077.


We gratefully acknowledge the assistance of C. Lohnes, J. Dennhardt, A. Fitzgerald, E. Heintzen, L. Carpenter, Ling Yan, J. Hartlein, T. Pretorius, A. Strongosky, J. Searcy, H. Lam, and C. Lim with subject enrollment and data collection.

The publisher regrets the error.